<?xml version="1.0" encoding="UTF-8"?>
<ref id="B127-pharmaceuticals-12-00157">
 <label>127.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Xie</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Ogah</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Shen</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Nucleoside inhibitors of hepatitis C virus NS5B polymerase: A systematic review</article-title>
  <source>Curr. Drug Targets</source>
  <year>2016</year>
  <volume>17</volume>
  <fpage>1560</fpage>
  <lpage>1576</lpage>
  <pub-id pub-id-type="doi">10.2174/1389450117666151209123751</pub-id>
  <?supplied-pmid 26648061?>
  <pub-id pub-id-type="pmid">26648061</pub-id>
 </element-citation>
</ref>
